Abstract
Case report A 29 year old HIV positive female was initiated on ART on 5/11/2012 with first line regimen, (TDF+3TC+NVP) as patient was anaemic. Patient came back with Nevirapine rash and ART was stopped on 20/12/12. Nevirapine was substituted with Efavirenz after rashes healed on 2/1/13. Patient developed severe itching with rashes just after three doses and hence ART was stopped. After one month, she was counseled, hospitalized and was rechallenged with only TDF+3TC; patient again developed severe itching with only one dose. Hence, patient was challenged with only lamivudine. With just one dose of lamivudine, patient developed hypersensitivity reaction within few hours with facial oedema, redness, tightness of skin with maculopapular rash and generalized blanchable erythema, giddiness, and hypotension and collapsed. She was resuscitated with dopamine, IV fluids and antihistamines.
Highlights
Lamivudine is a dideoxy nucleoside analogue – NRTI, widely used in the treatment of HIV infection
A 29 year old HIV positive female was initiated on ART
ART was stopped on 20/12/12
Summary
Leelavathy Budamakuntla1*, Prabhakar Basappa[2], Vidya Shankar[2], Nirmala[2], Ravi Kumar[1], Shwetha Suryanarayana[1]. From 2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014) Chennai, India. From 2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014) Chennai, India. 30 January - 1 February 2014
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
